Jill Alldredge, MD
Gynecologic Oncology · Aurora, CONPI 1558653451
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (57.5%), grants and food and beverage — rather than concentrated in one kind of arrangement. AstraZeneca accounts for 95.0% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2023 at $4,063 and has fallen 99.3% since, to $30 in 2025. That places this record below the midpoint for gynecologic oncology clinicians in CO, where the typical reported total is $4,511.
Across 10 payments — averaging $417.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$4K
- GSK$94
- Intuitive Surgical$56
- Eisai Inc.$30
- Coopersurgical, Inc.$19
- Clovis Oncology, Inc.$10
Across 29 payments — averaging $18,795 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merck$348K
- Clovis Oncology, Inc.$185K
- Astrazeneca UK Limited$12K
What the payments were for
- Consulting fees$2,39857%
- Grants$1,56638%
- Food & beverage$1995%
- Education$100%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 3 | $3,963 |
| GSK | 1 | $94 |
| Intuitive Surgical | 3 | $56 |
| Eisai Inc. | 1 | $30 |
| Coopersurgical, Inc. | 1 | $19 |
| Clovis Oncology, Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYNPARZA$2,398
How this compares
$4,172 in reported general payments places this provider in the 45th percentile of 28 gynecologic oncology providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LynparzaOlaparib | 11 | $178,307 |
| Estradiol | 19 | $4,969 |
| Megestrol Acetate | 26 | $899 |
| Dexamethasone | 27 | $445 |
| Letrozole | 18 | $332 |
| Ondansetron Hcl | 20 | $301 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 18 | $220 |
| Prochlorperazine Maleate | 20 | $202 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 14 | $177 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaLynparza | $3,963 | $178,30711 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 28 gynecologic oncology providers in Colorado.
Other gynecologic oncology in Aurora
- Bradley CorrAurora$70K
- Saketh GuntupalliAurora$39K
- Carolyn LefkowitsAurora$11K
- Kian BehbakhtAurora$10K
- Christine WalshAurora$8K
- Lindsay BrubakerAurora$7K
- Jaime ArrudaAurora$4K
- Joseph DemariAurora$1K
- Ashley GreenwoodAurora$475
- Eseohi EhimiagheAurora$334
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.